AI Maverick Intel (OTC: AIMV) announced the appointment of Dr. Wayne Young, BSc, DDS, to its Board of Directors, a move that comes as the company advances a definitive agreement to acquire 100% of the issued and outstanding shares of HEAL Access Canada Inc. from HEAL Group Holdings Inc., subject to certain closing conditions. The AI Maverick Intel (OTC: AIMV) board addition and the pending acquisition together underscore the company’s intent to build an operating platform in artificial intelligence–enabled healthcare.
Young brings more than three decades of healthcare, clinical, business and leadership experience. His appointment is expected to provide strategic guidance as the company seeks to integrate HEAL Access as the foundation of its operating strategy. AI Maverick Intel said the acquisition is intended to establish HEAL Access as the initial platform for applying AI and data technologies to healthcare and related markets, while the company evaluates complementary opportunities that can leverage AI to address real-world healthcare needs.
In a separate development, AI Maverick Intel (OTC Pink: AIMV) announced a settlement with Stronghold Media Group Corp. under which the parties mutually rescinded their August 2024 transaction and resolved their respective obligations related to the transaction. The associated intellectual property was reassigned to Stronghold Group. The settlement clears a prior transaction from the company’s plate as it focuses on the HEAL Access acquisition and its broader corporate transition.
As part of that transition, AIMV plans to complete a corporate name change and expects to announce its new name and identity following completion of the necessary corporate and regulatory processes. The name change, combined with the board appointment and the HEAL Access deal, points to a rebranding effort aligned with the company’s stated focus on AI-driven healthcare.
The news matters because it signals a strategic pivot for a small OTC-traded company into a sector where AI applications are attracting significant investor and industry attention. By bringing on a seasoned healthcare executive and pursuing an acquisition that would serve as an operating foundation, AI Maverick Intel is attempting to move beyond its prior media-related transaction and position itself in the healthcare technology space. For investors, the key questions will be whether the HEAL Access acquisition closes on the stated conditions and how quickly the company can integrate the business and execute on its AI healthcare strategy.
AI Maverick Intel is a Delaware corporation whose common shares are quoted on OTC Markets under the symbol AIMV. The company is focused on building and growing operating businesses that apply artificial intelligence and data technologies to healthcare and related markets, with HEAL Access intended as the initial platform for this strategy. The latest news and updates relating to AIMV are available in the company’s newsroom at http://nnw.fm/AIMV.
NetworkNewsWire, a specialized communications platform focused on financial news and content distribution, published the announcement. It is one of 75+ brands within the Dynamic Brand Portfolio at IBN, delivering wire solutions through InvestorWire, article and editorial syndication to 5,000+ outlets, press release enhancement, social media distribution and tailored corporate communications solutions. Full terms of use and disclaimers applicable to all content provided by NetworkNewsWire are available at https://www.NetworkNewsWire.com/Disclaimer.
